26/06 Indices, page-127

"Tradable? Yes. buy-and-hold, down -2.14%."

Tradable? No. Buy-and-hold, yes.

Firstly, CSL dominates XHJ, it represents more than 50% of XHJ. (even companies like Resmed, Ansell, Sonic, Ramsay are dwarfed by CSL)
Therefore when we talk about the Buy-and-hold performance of XHJ, we are basically talking about the Buy-and-hold performance of CSL.

I am such a buy-and-hold CSL shareholder. My initial IPO allocation at $2.40 per share in 1994 is now worth $1,400 per share, for a total return of only 58,000% or a 29-year CAGR of 25%. (includes dividend re-investment and the 1:3 split in 2007). Only Apple can rival this performance over such a long period of time.
My question to you is this: Where did I go wrong?

Secondly, you seem to be dissatisfied by CSL's Apple like performance (58,000%) and you want to try your luck at capturing the staggering 2.14% trading profit. This would require you to do 2 things:

1) You predicted the Covid pandemic and its effect on CSL's plasma collection costs. Prove it!
2) You predicted that on the 14th of June this year, CSL would issue a market update regarding a currency headwind and its effect on profits. You knew that CSL's reporting currency is the $US whereas more than 50% of its revenue is derived from non-US jurisdictions whose currency depreciated against the US dollar this year. You knew all that, and you warned us about it. Prove it!